Skip to Content
Silicon Valley

Facebook wants banks to hand over customers’ financial information

August 6, 2018

According to the Wall Street Journal, the company has reached out to JPMorgan Chase, Wells Fargo, Citigroup, and US Bankcorp to discuss joining forces with Facebook Messenger.

Why? Facebook would reportedly use the information to build new features, like the ability for users to check their account balance or to get fraud alerts through Messenger. In exchange, banks would have to provide data on its customers’ transactions and balances. The social network says the information would only be used for creating new features, not for ad targeting.

But... The legacy of the Cambridge Analytica scandal looms large. Banks have reportedly been hesitant to collaborate with the tech giant because of data privacy concerns, and one bank pulled out of talks entirely.

Going offline: Facebook is increasingly trying to gain access to your offline data to bolster its profile of users and provide more features. Earlier this year they even reached out to hospitals about getting medical data on users. Facebook isn’t alone, either. Other tech giants like Google also want access to your offline information—because if they don’t get it, the thinking goes, their competitors will.

Keep Reading

Most Popular

open sourcing language models concept
open sourcing language models concept

Meta has built a massive new language AI—and it’s giving it away for free

Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3

transplant surgery
transplant surgery

The gene-edited pig heart given to a dying patient was infected with a pig virus

The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.

Muhammad bin Salman funds anti-aging research
Muhammad bin Salman funds anti-aging research

Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging

The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.

Yann LeCun
Yann LeCun

Yann LeCun has a bold new vision for the future of AI

One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.